Akiko Wakisaka, Koichi Kimura, Hiroyuki Morita, Koki Nakanishi, Masao Daimon, Masanori Nojima, Hideki Itoh, Atsuhito Takeda, Ruriko Kitao, Tomihiro Imai, Tetsuhiko Ikeda, Takashi Nakajima, Chigusa Watanabe, Toshihiro Furukawa, Ichiro Ohno, Chiho Ishida, Norihiko Takeda, Kiyonobu Komai
Duchenne muscular dystrophy (DMD) is an intractable X-linked myopathy caused by dystrophin gene mutations. Patients with DMD suffer from progressive muscle weakness, inevitable cardiomyopathy, increased heart rate (HR), and decreased blood pressure (BP). The aim of this study was to clarify the efficacy and tolerability of ivabradine treatment for DMD cardiomyopathy.A retrospective analysis was performed in 11 patients with DMD, who received ivabradine treatment for more than 1 year. Clinical results were analyzed before (baseline), 6 months after, and 12 months after the ivabradine administration...
2024: International Heart Journal